Related Experiment Videos
AIDS: clinical and scientific issues past, present and future
A G Dalgleish1, G J Moyle, P Easterbrook
1Division of Oncology, St. George's Hospital Medical School, London, U.K.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|September 1, 1995
Summary
Despite slowed progress in new treatments and vaccines for acquired immunodeficiency syndrome (AIDS), significant advancements in managing human immunodeficiency virus (HIV) disease have improved patient survival and opportunistic infection control.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
- Public Health
Background:
- Acquired immunodeficiency syndrome (AIDS) emerged as a significant infectious disease challenge.
- Human immunodeficiency virus (HIV) was identified as the causative agent, with early antiviral therapies showing initial promise.
- Recent years have seen a deceleration in progress, with limited optimism from new treatments or vaccines.
Purpose of the Study:
- To review major advances in understanding AIDS and HIV disease management.
- To identify key challenges in both clinical and basic research for the future.
- To highlight improvements in managing HIV despite the absence of a cure.
Main Methods:
- Literature review of scientific publications on AIDS and HIV.
- Analysis of clinical management strategies and outcomes.
- Identification of trends in opportunistic infection treatment and prophylaxis.
- Assessment of shifts in the clinical spectrum of HIV-related disease.
Main Results:
- Early recognition of AIDS as infectious and rapid identification of HIV and early antivirals.
- Significant improvements in managing opportunistic infections, including prophylactic treatments.
- Altered clinical presentation of HIV disease, with prolonged survival despite low CD4 counts.
- Emergence of non-Hodgkin's lymphoma as a prominent HIV-related malignancy.
Conclusions:
- While progress in curative treatments and vaccines for HIV/AIDS has slowed, substantial gains have been made in disease management.
- Prophylaxis and treatment of opportunistic infections have dramatically improved patient outcomes and altered the disease's clinical course.
- Future efforts must address persistent challenges in both clinical care and fundamental research to further combat HIV/AIDS.